FDA.reportPublic FDA data

0.25 ML Vabrinty 30 MG/ML Prefilled Syringe

RxCUI
2728996
RxNorm name
0.25 ML Vabrinty 30 MG/ML Prefilled Syringe
Display name
0.25 ML Vabrinty 30 MG/ML Prefilled Syringe
Full name
0.25 ML Vabrinty 30 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VabrintyLEUPROLIDE ACETATEURONOVA PHARMACEUTICALS, INC.008776cc-83f1-4f8c-819b-6471425da15f2026-04-30Warnings, Adverse reactionsExact identifier
rxcui: 2728996

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
008776cc-83f1-4f8c-819b-6471425da15f0.25 ML Vabrinty 30 MG/ML Prefilled SyringeSY9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601
008776cc-83f1-4f8c-819b-6471425da15f0.25 ML leuprolide acetate 30 MG/ML Prefilled Syringe [Vabrinty]SBD9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601
008776cc-83f1-4f8c-819b-6471425da15fVabrinty 7.5 MG per 0.25 ML Prefilled SyringeSY9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601
008776cc-83f1-4f8c-819b-6471425da15fVabrinty 7.5 MG in 0.25 ML (1 month) Prefilled SyringePSN9These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220250601